FDA.reportPublic FDA data

olsalazine sodium 250 MG Oral Capsule [Dipentum]

RxCUI
905164
RxNorm name
olsalazine sodium 250 MG Oral Capsule [Dipentum]
Display name
olsalazine sodium 250 MG Oral Capsule [Dipentum]
Full name
olsalazine sodium 250 MG Oral Capsule [Dipentum]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DipentumOLSALAZINE SODIUMViatris Specialty LLC8512d0c6-db4e-4673-b3b4-28975c18413f2026-05-15Warnings, Adverse reactionsExact identifier
rxcui: 905164

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8512d0c6-db4e-4673-b3b4-28975c18413fDipentum 250 MG Oral Capsule [PSN] · olsalazine sodium 250 MG Oral Capsule [Dipentum] [SBD] · Dipentum 250 MG Oral Capsule [SY]315These highlights do not include all the information needed to use DIPENTUM safely and effectively. See full prescribing information for DIPENTUM . DIPENTUM (olsalazine sodium) capsules, for oral use Initial U.S. Approval: 198720240718
9dd522a3-587e-44ab-9de3-a0fd079f2ffbDipentum 250 MG Oral Capsule [PSN] · olsalazine sodium 250 MG Oral Capsule [Dipentum] [SBD] · Dipentum 250 MG Oral Capsule [SY]33Pr Dipentum ® (olsalazine sodium) capsule, gelatin coated Rx Only CIP70006A PT#CIA60342 Rev. 1/2014 CIP70006A20171226
373c321f-cd33-4c11-a2d6-73f38384c27fDipentum 250 MG Oral Capsule [PSN] · olsalazine sodium 250 MG Oral Capsule [Dipentum] [SBD] · Dipentum 250 MG Oral Capsule [SY]32Dipentum (olsalazine sodium capsules) ®20091005